BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38049150)

  • 1. The Groundbreaking Validation of Whole Genome Sequencing (WGS) for a Comprehensive Genetic Profiling of Childhood B-cell ALL.
    Garcia-Heras J
    J Assoc Genet Technol; 2023; 49(4):156-161. PubMed ID: 38049150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLT3 Gene Involvement in B-cell Acute Lymphoblastic Leukemia (B-ALL).
    Garcia-Heras J
    J Assoc Genet Technol; 2023; 49(4):151-155. PubMed ID: 38049152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.
    Ryan SL; Peden JF; Kingsbury Z; Schwab CJ; James T; Polonen P; Mijuskovic M; Becq J; Yim R; Cranston RE; Hedges DJ; Roberts KG; Mullighan CG; Vora A; Russell LJ; Bain R; Moorman AV; Bentley DR; Harrison CJ; Ross MT
    Leukemia; 2023 Mar; 37(3):518-528. PubMed ID: 36658389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Confirmatory Diagnostic Value of Whole Genome Sequencing (WGS) as a Standalone Test for Childhood B-cell ALL: The Results of a NOPHO Trials Cohort.
    Garcia-Heras J
    J Assoc Genet Technol; 2023; 49(4):162-166. PubMed ID: 38049148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
    Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
    Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
    Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D
    Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
    Leongamornlert D; Gutiérrez-Abril J; Lee S; Barretta E; Creasey T; Gundem G; Levine MF; Arango-Ossa JE; Liosis K; Medina-Martinez JS; Zuborne Alapi K; Kirkwood AA; Clifton-Hadley L; Patrick P; Jones D; O'Neill L; Butler AP; Harrison CJ; Campbell P; Patel B; Moorman AV; Fielding AK; Papaemmanuil E
    Blood Adv; 2023 Aug; 7(15):3862-3873. PubMed ID: 36867579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test development, optimization and validation of a WGS pipeline for genetic disorders.
    Yang Z; Yang X; Sun Y; Wang Y; Song L; Qiao Z; Fang Z; Wang Z; Liu L; Chen Y; Yan S; Guo X; Zhang J; Fan C; Liu F; Peng Z; Peng H; Sun J; Chen W
    BMC Med Genomics; 2023 Apr; 16(1):74. PubMed ID: 37020281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia.
    Walter W; Shahswar R; Stengel A; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    BMC Cancer; 2021 Aug; 21(1):886. PubMed ID: 34340673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinically validated whole genome pipeline for structural variant detection and analysis.
    Neerman N; Faust G; Meeks N; Modai S; Kalfon L; Falik-Zaccai T; Kaplun A
    BMC Genomics; 2019 Jul; 20(Suppl 8):545. PubMed ID: 31307387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of undetected, clinically relevant chromosome abnormalities when replacing postnatal karyotyping by Whole Genome Sequencing.
    Hochstenbach R; van Binsbergen E; Schuring-Blom H; Buijs A; Ploos van Amstel HK
    Eur J Med Genet; 2019 Sep; 62(9):103543. PubMed ID: 30248410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive preimplantation genetic testing by massively parallel sequencing.
    Chen S; Yin X; Zhang S; Xia J; Liu P; Xie P; Yan H; Liang X; Zhang J; Chen Y; Fei H; Zhang L; Hu Y; Jiang H; Lin G; Chen F; Xu C
    Hum Reprod; 2021 Jan; 36(1):236-247. PubMed ID: 33306794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GENType: all-in-one preimplantation genetic testing by pedigree haplotyping and copy number profiling suitable for third-party reproduction.
    De Witte L; Raman L; Baetens M; De Koker A; Callewaert N; Symoens S; Tilleman K; Vanden Meerschaut F; Dheedene A; Menten B
    Hum Reprod; 2022 Jun; 37(7):1678-1691. PubMed ID: 35552408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia.
    Rezayee F; Eisfeldt J; Skaftason A; Öfverholm I; Sayyab S; Syvänen AC; Maqbool K; Lilljebjörn H; Johansson B; Olsson-Arvidsson L; Pietras CO; Staffas A; Palmqvist L; Fioretos T; Cavelier L; Fogelstrand L; Nordlund J; Wirta V; Rosenquist R; Barbany G
    Front Oncol; 2023; 13():1217712. PubMed ID: 37664045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia.
    Othman MA; Melo JB; Carreira IM; Rincic M; Glaser A; Grygalewicz B; Gruhn B; Wilhelm K; Rittscher K; Meyer B; Silva ML; de Jesus Marques Salles T; Liehr T
    Mol Cytogenet; 2015; 8():45. PubMed ID: 26136832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.
    Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S
    Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ONT long-read WGS for variant discovery and orthogonal confirmation of short read WGS derived genetic variants in clinical genetic testing.
    Kaplun L; Krautz-Peterson G; Neerman N; Stanley C; Hussey S; Folwick M; McGarry A; Weiss S; Kaplun A
    Front Genet; 2023; 14():1145285. PubMed ID: 37152986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of multiplex ligation-dependent probe amplification (MLPA) and low pass whole genome sequencing (LP-WGS) to the classification / characterisation of low grade glioneuronal tumours.
    Dyke J; Calapre L; Beasley A; Gray E; Allcock R; Bentel J
    Pathol Res Pract; 2022 Jan; 229():153724. PubMed ID: 34942511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
    Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
    Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of complex chromosomal rearrangements using a combination of current molecular cytogenetic techniques.
    He P; Wei X; Xu Y; Huang J; Tang N; Yan T; Yang C; Lu K
    Mol Cytogenet; 2022 May; 15(1):20. PubMed ID: 35590339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.